The Gravitate-Health is a public – private partnership with 45 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI2 Associated Partners.  

This summer issue of the newsletter inclused:

🔹Highlights from the participation of Gravitate-Health to strategic events such as HIMSSEurope2025 in Paris and the Patient Engagement Open Forum in Baveno.

🔹Updates from key meetings of the ePI Technology Community and the Open E2E Community

🔹Ongoing third test of the Gravitate Health app functionalities

🔹Scientific articles